Bron D - Search Results

1

Time to relapse has prognostic value in patients with aggressive lymphoma enrolled onto the Parma trial.

Guglielmi C, Gomez F, Philip T, Hagenbeek A, Martelli M, Sebban C, Milpied N, Bron D, Cahn JY, Somers R, Sonneveld P, Gisselbrecht C, Van Der Lelie H, Chauvin F. Guglielmi C, et al. Among authors: bron d. J Clin Oncol. 1998 Oct;16(10):3264-9. doi: 10.1200/JCO.1998.16.10.3264. J Clin Oncol. 1998. PMID: 9779700 Clinical Trial.

2

PARMA international protocol: pilot study on 50 patients and preliminary analysis of the ongoing randomized study (62 patients).

Philip T, Chauvin F, Bron D, Guglielmi C, Hagenbeek A, Coiffier B, Gisselbrecht C, Kluin Nelemans JC, Somers R, Misset JC, et al. Philip T, et al. Among authors: bron d. Ann Oncol. 1991 Jan;2 Suppl 1:57-64. doi: 10.1093/annonc/2.suppl_1.57. Ann Oncol. 1991. PMID: 2043500 Free article. Clinical Trial.

3

The Parma international randomized study in relapsed non Hodgkin lymphoma: 1st interim analysis of 128 patients (as 15 January 1991: 153 patients).

Hagenbeek A, Philip T, Bron D, Guglielmi C, Coiffier B, Gisselbrecht C, Kluin Nelemans JC, Somers R, Misset JL, Van der Lely J, et al. Hagenbeek A, et al. Among authors: bron d. Bone Marrow Transplant. 1991;7 Suppl 2:142. Bone Marrow Transplant. 1991. PMID: 1878684 Clinical Trial. No abstract available.

4

Parma international protocol: pilot study of DHAP followed by involved-field radiotherapy and BEAC with autologous bone marrow transplantation.

Philip T, Chauvin F, Armitage J, Bron D, Hagenbeek A, Biron P, Spitzer G, Velasquez W, Weisenburger DD, Fernandez-Ranada J, et al. Philip T, et al. Among authors: bron d. Blood. 1991 Apr 1;77(7):1587-92. Blood. 1991. PMID: 2009374 Free article. Clinical Trial.

5

Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma.

Philip T, Guglielmi C, Hagenbeek A, Somers R, Van der Lelie H, Bron D, Sonneveld P, Gisselbrecht C, Cahn JY, Harousseau JL, et al. Philip T, et al. Among authors: bron d. N Engl J Med. 1995 Dec 7;333(23):1540-5. doi: 10.1056/NEJM199512073332305. N Engl J Med. 1995. PMID: 7477169 Free article. Clinical Trial.

6

CHOP is the standard regimen in patients > or = 70 years of age with intermediate-grade and high-grade non-Hodgkin's lymphoma: results of a randomized study of the European Organization for Research and Treatment of Cancer Lymphoma Cooperative Study Group.

Tirelli U, Errante D, Van Glabbeke M, Teodorovic I, Kluin-Nelemans JC, Thomas J, Bron D, Rosti G, Somers R, Zagonel V, Noordijk EM. Tirelli U, et al. Among authors: bron d. J Clin Oncol. 1998 Jan;16(1):27-34. doi: 10.1200/JCO.1998.16.1.27. J Clin Oncol. 1998. PMID: 9440719 Clinical Trial.

7

Persistent improved results after adding vincristine and bleomycin to a cyclophosphamide/hydroxorubicin/Vm-26/prednisone combination (CHVmP) in stage III-IV intermediate- and high-grade non-Hodgkin's lymphoma. The EORTC Lymphoma Cooperative Group.

Meerwaldt JH, Carde P, Somers R, Thomas J, Kluin-Nelemans JC, Bron D, Noordijk EM, Cosset JM, Bijnens L, Teodorovic I, Hagenbeek A. Meerwaldt JH, et al. Among authors: bron d. Ann Oncol. 1997;8 Suppl 1:67-70. Ann Oncol. 1997. PMID: 9187434 Clinical Trial.

8

EORTC study of non-Hodgkin's lymphoma: phase III study comparing CHVmP-VB and ProMACE-MOPP in patients with stage II, III, and IV intermediate- and high-grade lymphoma.

Somers R, Carde P, Thomas J, Tirelli U, Keuning JJ, Bron D, Delmer A, de Bock R, De Wolf-Peeters C, Keunig JJ, et al. Somers R, et al. Among authors: bron d. Ann Oncol. 1994;5 Suppl 2:85-9. doi: 10.1093/annonc/5.suppl_2.s85. Ann Oncol. 1994. PMID: 7515651 Clinical Trial.

9

Higher incidence of relapse in patients with acute myelocytic leukemia infused with higher doses of CD34+ cells from leukapheresis products autografted during the first remission.

Gorin NC, Labopin M, Reiffers J, Milpied N, Blaise D, Witz F, de Witte T, Meloni G, Attal M, Bernal T, Rocha V; Acute Leukemia Working Party, European Cooperative Group for Blood and Marrow Transplantation. Gorin NC, et al. Blood. 2010 Oct 28;116(17):3157-62. doi: 10.1182/blood-2009-11-252197. Epub 2010 May 17. Blood. 2010. PMID: 20479285 Free article.

10

Outcome of patients developing GVHD after DLI given to treat CML relapse: a study by the Chronic Leukemia Working Party of the EBMT.

Chalandon Y, Passweg JR, Schmid C, Olavarria E, Dazzi F, Simula MP, Ljungman P, Schattenberg A, de Witte T, Lenhoff S, Jacobs P, Volin L, Iacobelli S, Finke J, Niederwieser D, Guglielmi C; Chronic Leukemia Working Party of European Group for Blood and Marrow Transplantation. Chalandon Y, et al. Bone Marrow Transplant. 2010 Mar;45(3):558-64. doi: 10.1038/bmt.2009.177. Epub 2009 Jul 27. Bone Marrow Transplant. 2010. PMID: 19633691

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

346 results

Search Page

Filters